Wanmuang, HarirakLeopairut, JuvadyKositchaiwat, ChomsriWananukul, WinaiBunyaratvej, Sukhum2009-05-272009-05-272007-01-12Wanmuang H, Leopairut J, Kositchaiwat C, Wananukul W, Bunyaratvej S. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. Journal of the Medical Association of Thailand. 2007 Jan; 90(1): 179-81http://imsear.searo.who.int/handle/123456789/42785Chotmaihet Thangphaet.Hepatotoxic effect related to Ganoderma lucidum (Lingzhi) mushroom powder was first described in a patient from Hong Kong in 2004. In 2005, the authors experienced a case of fatal fulminant hepatitis associated with such a preparation. Both patients had taken other therapeutic agents and traditionally boiled Lingzhi without any toxic effect. After switching to taking Lingzhi in powder form for 1-2 months, the hepatotoxic episode occurred in both patients. The toxic role of Lingzhi powder needs close monitoring in the future, especially in combination with other drugs.engDrugs, Chinese Herbal --poisoningFatal OutcomeFemaleHepatitis, Toxic --etiologyHumansLiver --pathologyLiver Failure, Acute --etiologyMiddle AgedPowdersWound HealingCase Reports